Mehmud Faisal 4
4 · Medicus Pharma Ltd. · Filed Jul 24, 2025
Insider Transaction Report
Form 4
Mehmud Faisal
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2025-07-22+50,000→ 50,000 totalExercise: $3.08Exp: 2030-07-22→ Common Shares (50,000 underlying)
Holdings
- 100,000
Stock Option (right to buy)
Exercise: $2.26Exp: 2029-11-14→ Common Shares (100,000 underlying)
Footnotes (3)
- [F1]Represents an exercise price of $3.25 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.4379 reported by the Bank of Canada on December 30, 2024.
- [F2]The board of directors of Medicus Pharma Ltd. (the ?Board?) approved, during a Board meeting held on July 22, 2025, accelerated vesting of the Reporting Person's options that were otherwise unvested and scheduled to vest annually in five equal installments beginning on November 14, 2025. All these options are now vested.
- [F3]The option was granted on July 22, 2025. The option is scheduled to vest quarterly in four equal installments over one year.